EBR

EBR SYSTEM CDI FORUS [EBR]
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
Healthcare · ASX Small Cap
$0.2800 +0.0%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when EBR triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track EBR — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Adequate cash runway (5 quarters)
  • Strong revenue growth (+1451%)
  • EPS estimates revised downward (-10pts)
  • Near 52-week low (3% of range)
  • Capital raise activity (1 events)
  • CANSLIM I: Institutional ownership (38%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 76% over the past year
  • Poor risk-adjusted returns — Sharpe of -2.1 means lots of volatility for not much reward
  • Revenue growing at +1451% — the top line is moving in the right direction
  • Altman Z-Score distress zone (1.59 < 1.81, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.82%/day)
Ask Scout AI about EBR
"What's driving EBR today?" "How does EBR compare to peers?" "Key risks for EBR?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Cleansing Notice
NONE Application for quotation of securities - EBR
NONE Form S-8 Registration Statement

Recent ASX Announcements

2026-08-25 Cleansing Notice
2026-08-25 Application for quotation of securities - EBR
2026-08-24 Form S-8 Registration Statement
2026-08-20 Transition of Chief Commercial Officer
2026-08-19 Results of Meeting

Key Metrics

$210.9M
Market Cap
2.3M
Avg Volume
0.5x
Vol Ratio
$0.24 — $1.47
52-Week Range
0.3%
Short Interest
N/A
Cash Runway
-102.5%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 79%
LLeader vs LaggardlaggardRS: -13
IInstitutional SponsorshippassInst: 38%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%BIT -20.0%MEM +20.0%CMP -14.6%
Compare:EBR vs REGEBR vs CANEBR vs BIT
Scout Pro — Deeper Analysis for EBR
Try Pro free for 30 days
Share this analysis

Track EBR and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required